MMS’s OncoScan System uses passive, non-invasive microwave radiometry to measure naturally occurring electromagnetic emissions from the human body for the early detection of breast cancer. The body has a core temperature of 37˚C. However, breast temperature, like that of the arms and legs, is a cooler 34.5˚C. Due to the process of angiogenesis, which sends core temperature blood to a tumor, a tumor registers a higher temperature than the surrounding breast tissue. Since angiogenesis precedes tumor growth and metastasis, using microwave radiometry to determine thermal activity provides an early means of tumor detection years before traditional mammography or palpitation.
Like infrared thermography, the use of microwave radiometry in cancer detection is based on the assumption that a temperature difference exists between a tumor and its surrounding tissue. Taking advantage of improved transmission characteristics, microwave radiometry, allows detection of temperature at depth. The OncoScan System is intended to detect thermal anomalies in breast tissue. It is not intended to be a stand-alone test, but when used in conjunction with clinical breast exams and mammography can provide the physician with additional information to help guide a decision to biopsy.
Applied ThermoLogic’s engineering team is available to support microwave companies and medical facilities interested in this product.